您的位置: 首页 > 农业专利 > 详情页

VACCIN CONTRE DES MALADIES DUES AU VIRUS EBOLA UTILISANT UN ADÉNOVIRUS HUMAIN À RÉPLICATION DÉFICIENTE COMME VECTEUR
专利权人:
Institute of Biotechnology; Academy of Military Medical Sciences; Pla.
发明人:
申请号:
EP16887656.3
公开号:
EP3342865A1
申请日:
2016.10.24
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
Provided are an Ebola virus envelope glycoprotein (that is GP protein) codon optimized nucleotide sequence, a human replication deficient recombinant adenovirus capable of expressing the nucleotide sequence, and applications in preparing a vaccine for preventing Ebola virus diseases. The nucleotide sequence takes a replication deficient 5 type adenovirus that is lack of E1 and E3 in a combined mode as a vector, HEK293 cells that integrate adenovirus E1 genes serve as a packaging cell line, and carried protective antigenic genes are codon optimized Zaire type Ebola virus Makona strain envelope glycoprotein genes. After the envelope glycoprotein genes are optimized by codon, the expression level in transfection cells is obviously improved.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充